Pharma Ag Novartis, 10% Owner at IDENIX PHARMACEUTICALS INC (IDIX), bought 84,893 shares at $3.04 ($291K) on 2012-02-23, disclosed to the SEC on 2012-02-23.
Open-market purchase of $291k IDIX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.41 | 35,735 | $86K | 29.6% |
| 2 | $2.47 | 366 | $904 | 0.3% |
| 3 | $2.56 | 2,493 | $6K | 2.2% |
| 4 | $2.69 | 997 | $3K | 0.9% |
| 5 | $2.78 | 997 | $3K | 1.0% |
| 6 | $2.85 | 1,321 |
| $4K |
| 1.3% |
| 7 | $2.90 | 3,117 | $9K | 3.1% |
| 8 | $2.96 | 8,960 | $27K | 9.1% |
| 9 | $2.97 | 427 | $1K | 0.4% |
| 10 | $3.04 | 232 | $705 | 0.2% |
| 11 | $3.17 | 4,336 | $14K | 4.7% |
| 12 | $3.79 | 3,093 | $12K | 4.0% |
| 13 | $5.10 | 39 | $199 | 0.1% |
| 14 | $5.11 | 11,433 | $58K | 20.1% |
| 15 | $5.46 | 7,402 | $40K | 13.9% |
| 16 | $5.79 | 883 | $5K | 1.8% |
| 17 | $5.80 | 436 | $3K | 0.9% |
| 18 | $6.52 | 493 | $3K | 1.1% |
| 19 | $7.39 | 2,133 | $16K | 5.4% |
| Total | $3.43 avg | 84,893 | $291K | 100% |
| Filing → |
| IDIX | BUY | 2011-11-22 | $206K | — | Filing → |
| IDIX | BUY | 2010-11-26 | $47K | — | Filing → |
| IDIX | BUY | 2010-09-16 | $91K | — | Filing → |